{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:42:16Z","timestamp":1772890936452,"version":"3.50.1"},"reference-count":161,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.carrev.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T02:38:25Z","timestamp":1590460705000},"page":"1041-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Periprocedural Myocardial Injury: Pathophysiology, Prognosis, and Prevention"],"prefix":"10.1016","volume":"21","author":[{"given":"Mohamad","family":"Soud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Hideo-Kajita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Yacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8ne P.","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.04.011_bb0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","volume":"36","author":"Antman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCINTERVENTIONS.110.957712","article-title":"Prognostic value of isolated troponin I elevation after percutaneous coronary intervention","volume":"3","author":"Cavallini","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.amjcard.2008.10.044","article-title":"Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery","volume":"103","author":"De Labriolle","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0020","doi-asserted-by":"crossref","unstructured":"Kini AS, Lee P, Marmur JD, Agarwal A, Duffy ME, Kim MC, et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol.93:18\u201323.","DOI":"10.1016\/j.amjcard.2003.09.006"},{"key":"10.1016\/j.carrev.2020.04.011_bb0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehi760","article-title":"Baseline troponin level: key to understanding the importance of post-PCI troponin elevations","volume":"27","author":"Miller","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCINTERVENTIONS.108.765610","article-title":"Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients","volume":"1","author":"Prasad","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.CIR.0000028146.71416.2E","article-title":"Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy","volume":"106","author":"Ellis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/hc3101.093902","article-title":"Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients","volume":"104","author":"Stone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0045","series-title":"Clinical end points in coronary stent trials. A case for standardized definitions","first-page":"2344","volume":"115","author":"Cutlip","year":"2007"},{"key":"10.1016\/j.carrev.2020.04.011_bb0050","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0055","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0060","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0065","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0070","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0075","series-title":"Variation in myocardial infarction rates by type and definition in the ISCHEMIA trial. American College of Cardiology annual meeting","author":"Chaitman","year":"2020"},{"key":"10.1016\/j.carrev.2020.04.011_bb0080","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jcin.2016.09.015","article-title":"Periprocedural myocardial infarction: the \u201cSCAI\u201d is the limit","volume":"9","author":"Stone","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMra0912134","article-title":"Myocardial infarction due to percutaneous coronary intervention","volume":"364","author":"Prasad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2018.06.034","article-title":"Definitions of peri-procedural myocardial infarction and the association with one-year mortality: insights from CHAMPION trials","volume":"270","author":"Olivier","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0095","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/eht048","article-title":"Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention","volume":"34","author":"Park","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.amjcard.2013.12.016","article-title":"Impact of the angiographic mechanisms underlying periprocedural myocardial infarction after drug-eluting stent implantation","volume":"113","author":"Park","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0105","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10554-014-0444-6","article-title":"Microcirculatory significance of periprocedural myocardial necrosis after percutaneous coronary intervention assessed by the index of microcirculatory resistance","volume":"30","author":"Wu","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0115","first-page":"655","article-title":"The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome","volume":"24","author":"Muschart","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0120","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.CIR.0000156328.28485.AD","article-title":"Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging","volume":"111","author":"Selvanayagam","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2011.07.096","article-title":"MRI study on volume effects of coronary emboli on myocardial function, perfusion and viability","volume":"165","author":"Saeed","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcin.2015.01.032","article-title":"Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY trial (coronary assessment by near-infrared of atherosclerotic rupture-prone yellow)","volume":"8","author":"Stone","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jcmg.2008.12.020","article-title":"Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis","volume":"2","author":"Hong","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0140","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.jacc.2016.08.059","article-title":"High-sensitivity troponin T and mortality after elective percutaneous coronary intervention","volume":"68","author":"Ndrepepa","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5603\/KP.a2013.0186","article-title":"TIMI myocardial perfusion grade and ST-segment resolution in the assessment of coronary reperfusion after primary angioplasty","volume":"72","author":"Horszczaruk","year":"2014","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0150","first-page":"616","article-title":"Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: results from a prospective, single center PCI registry","volume":"87","author":"Zhang","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0155","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1253\/circj.CJ-14-1375","article-title":"Association of intravascular ultrasound- and optical coherence tomography-assessed coronary plaque morphology with periprocedural myocardial injury in patients with stable angina pectoris","volume":"79","author":"Kimura","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon","volume":"105","author":"Rezkalla","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1536\/ihj.14-005","article-title":"Impact of coronary plaque burden and composition on periprocedural myocardial infarction and coronary flow reserve after percutaneous coronary intervention","volume":"55","author":"Higuchi","year":"2014","journal-title":"Int Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcin.2015.03.016","article-title":"Multimodality intravascular imaging to predict periprocedural myocardial infarction during percutaneous coronary intervention","volume":"8","author":"Kini","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0175","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2169\/internalmedicine.51.6732","article-title":"Deep echo attenuation without calcification increases the risk of periprocedural myonecrosis after elective percutaneous coronary intervention in patients with coronary artery disease","volume":"51","author":"Mitsuba","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5603\/KP.2013.0059","article-title":"Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound\/virtual histology study","volume":"71","author":"Michalak","year":"2013","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijcard.2015.01.021","article-title":"In vivo evaluation of fibrous cap thickness by optical coherence tomography for positive remodeling and low-attenuation plaques assessed by computed tomography angiography","volume":"182","author":"Sato","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcin.2008.08.022","article-title":"Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes","volume":"2","author":"Lee","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0195","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcmg.2014.07.020","article-title":"High-intensity plaques on noncontrast T1-weighted imaging as a predictor of periprocedural myocardial injury","volume":"8","author":"Asaumi","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MCA.0000000000000114","article-title":"Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation","volume":"25","author":"Ueda","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2020.04.011_bb0205","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjcard.2017.06.043","article-title":"Intraluminal intensity of blood speckle on intravascular ultrasound, a novel predictor of periprocedural myocardial injury after coronary stenting","volume":"120","author":"Okuya","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0210","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2012.01.051","article-title":"Impact of coronary plaque composition on cardiac troponin elevation after percutaneous coronary intervention in stable angina pectoris: a computed tomography analysis","volume":"59","author":"Watabe","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0215","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MCA.0000000000000651","article-title":"Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention","volume":"29","author":"Kang","year":"2018","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2020.04.011_bb0220","article-title":"Positive association of coronary calcium detected by computed tomography coronary angiography with periprocedural myocardial infarction","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.carrev.2020.04.011_bb0225","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jcmg.2009.01.016","article-title":"Characterization of hyperintense plaque with noncontrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound","volume":"2","author":"Kawasaki","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0230","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/eurheartj\/ehv187","article-title":"Coronary high-intensity plaque on T1-weighted magnetic resonance imaging and its association with myocardial injury after percutaneous coronary intervention","volume":"36","author":"Hoshi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/CIRCULATIONAHA.106.660779","article-title":"Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions","volume":"115","author":"Bahrmann","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0240","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jacc.2007.05.050","article-title":"The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation","volume":"50","author":"Kawamoto","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2012.10.013","volume":"6","author":"Muramatsu","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0250","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcin.2015.06.001","article-title":"Incidence and potential mechanism(s) of post-procedural rise of cardiac biomarker in patients with coronary artery narrowing after implantation of an everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent","volume":"8","author":"Ishibashi","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCINTERVENTIONS.109.887406","article-title":"Anatomic and functional evaluation of bifurcation lesions undergoing percutaneous coronary intervention","volume":"3","author":"Koo","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0260","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.carrev.2020.04.011_bb0265","doi-asserted-by":"crossref","unstructured":"Lansky AJ, Yaqub M, Hermiller JB, Smith RS, Farhat N, Caputo R, et al. Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention. 2010;6 Suppl J:J44\u201352.","DOI":"10.4244\/EIJV6SUPJA8"},{"key":"10.1016\/j.carrev.2020.04.011_bb0270","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.106.620476","article-title":"Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury","volume":"114","author":"Balian","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0275","doi-asserted-by":"crossref","unstructured":"Stiermaier T, Jobs A, de Waha S, Fuernau G, Poss J, Desch S, et al. Optimized prognosis assessment in st-segment-elevation myocardial infarction using a cardiac magnetic resonance imaging risk score. Circ Cardiovasc Imaging. 2017;10(11).","DOI":"10.1161\/CIRCIMAGING.117.006774"},{"key":"10.1016\/j.carrev.2020.04.011_bb0280","doi-asserted-by":"crossref","unstructured":"De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, et al. Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI. JACC Cardiovasc Imaging. 2019;12:837-48.","DOI":"10.1016\/j.jcmg.2018.02.018"},{"key":"10.1016\/j.carrev.2020.04.011_bb0285","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients","volume":"7","author":"van Kranenburg","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0290","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2014.06.1194","article-title":"Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction","volume":"64","author":"Eitel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1745-6215-15-249","article-title":"Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine","volume":"15","author":"de Waha","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.carrev.2020.04.011_bb0300","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/joic.12271","article-title":"The index of microcirculatory resistance postpercutaneous coronary intervention predicts left ventricular recovery in patients with thrombolyzed ST-segment elevation myocardial infarction","volume":"29","author":"Palmer","year":"2016","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0305","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/MCA.0000000000000213","article-title":"The index of microcirculatory resistance in the physiologic assessment of the coronary microcirculation","volume":"26","author":"Martinez","year":"2015","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2020.04.011_bb0310","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.jacc.2006.06.002","article-title":"Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function","volume":"48","author":"Steen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0315","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2004.02.046","article-title":"Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction","volume":"43","author":"Ingkanisorn","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9149(99)00191-5","article-title":"Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris","volume":"84","author":"Bertinchant","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12872-018-0767-7","article-title":"Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction - a prospective CMR study","volume":"18","author":"Poyhonen","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2020.04.011_bb0330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jacc.2007.09.041","article-title":"Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T","volume":"51","author":"Giannitsis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0335","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcin.2010.06.015","article-title":"New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?","volume":"3","author":"Locca","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0340","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jcmg.2009.03.023","article-title":"Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention","volume":"2","author":"Rodriguez-Granillo","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2015.01.085","article-title":"Presence of myocardial hypoenhancement on multidetector computed tomography after primary percutaneous coronary intervention in acute myocardial infarction predicts poor prognosis","volume":"184","author":"Ogasawara","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0350","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s12350-017-0930-z","article-title":"PET measurements of myocardial blood flow post myocardial infarction: relationship to invasive and cardiac magnetic resonance studies and potential clinical applications","volume":"24","author":"Gewirtz","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0355","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jcmg.2017.03.006","article-title":"Quantitative PET myocardial blood flow: \u201ctrust, but verify\u201d","volume":"10","author":"Dilsizian","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2020.04.011_bb0360","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcin.2009.12.012","article-title":"Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention","volume":"3","author":"Mangiacapra","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcin.2009.10.024","article-title":"High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention","volume":"3","author":"Mangiacapra","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0370","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1111\/jth.12016","article-title":"Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention","volume":"10","author":"Mangiacapra","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.carrev.2020.04.011_bb0375","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.amjcard.2008.02.054","article-title":"Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris","volume":"101","author":"Cuisset","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0380","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4244\/EIJV10I2A34","article-title":"Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the stent thrombosis in Belgium (STIB) trial","volume":"10","author":"Legrand","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.011_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2008.04.019","article-title":"Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease","volume":"395","author":"Papa","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.carrev.2020.04.011_bb0390","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12471-016-0850-6","article-title":"Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation","volume":"24","author":"Verdoia","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0395","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.amjcard.2016.07.015","article-title":"Relation of neutrophil to lymphocyte ratio with periprocedural myocardial damage in patients undergoing elective percutaneous coronary intervention","volume":"118","author":"Bressi","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0400","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2014.06.023","article-title":"Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions","volume":"236","author":"Verdoia","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2020.04.011_bb0405","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0410","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.ahj.2005.07.006","article-title":"Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina","volume":"151","author":"Goldberg","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/dmrr.2567","article-title":"Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation","volume":"31","author":"Verdoia","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.carrev.2020.04.011_bb0420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jdiacomp.2015.02.005","article-title":"Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients","volume":"29","author":"Verdoia","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.carrev.2020.04.011_bb0425","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/dmrr.2495","article-title":"Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention","volume":"30","author":"Verdoia","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.carrev.2020.04.011_bb0430","first-page":"847","article-title":"Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation","volume":"73","author":"Chambers","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0435","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCINTERVENTIONS.111.962233","article-title":"Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the evaluation of drug-eluting stents and ischemic events (EVENT) registry","volume":"4","author":"Lindsey","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0440","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/hrt.2005.078758","article-title":"Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk","volume":"92","author":"Chew","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2020.04.011_bb0445","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCA.0000000000000795","article-title":"Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients","volume":"31","author":"Soud","year":"2020","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2020.04.011_bb0450","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4244\/EIJ-D-19-00737","article-title":"Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospective studies","volume":"15","author":"Yuehua","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.011_bb0455","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jcin.2019.07.014","article-title":"Impact of periprocedural myocardial biomarker elevation on mortality following elective percutaneous coronary intervention","volume":"12","author":"Garcia-Garcia","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0460","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/eurheartj\/ehz113","article-title":"Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial","volume":"40","author":"Ben-Yehuda","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0465","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/eurheartj\/ehy219","article-title":"Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: thrombectomy trialists collaboration","volume":"39","author":"Mahmoud","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0470","first-page":"115","article-title":"Direct stenting may limit myocardial injury during percutaneous coronary intervention","volume":"15","author":"Nageh","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0475","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacc.2007.11.059","article-title":"Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation","volume":"51","author":"Cuisset","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0480","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJM198806303182603","article-title":"Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty","volume":"318","author":"Schwartz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0485","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0002-9149(90)90804-A","article-title":"Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty","volume":"65","author":"Lembo","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0490","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention","volume":"124","author":"Null","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0495","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.carrev.2020.04.011_bb0500","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","article-title":"Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review","volume":"153","author":"Hovens","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0505","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","article-title":"Ticlopidine and clopidogrel","volume":"100","author":"Quinn","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0510","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0515","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2020.04.011_bb0520","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.atherosclerosis.2006.12.009","article-title":"A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study","volume":"196","author":"Warnholtz","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2020.04.011_bb0525","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0530","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.amjcard.2005.10.064","article-title":"Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention","volume":"97","author":"Wolfram","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0535","doi-asserted-by":"crossref","unstructured":"Di Sciascio G, Patti G, Pasceri V, Gatto L, Colonna G, Montinaro A. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention. Results of the ARMYDA-5 PRELOAD (antiplatelet therapy for reduction of myocardial damage during angioplasty) Randomized Trial. J Am Coll Cardiol. 2010;56:550\u20137.","DOI":"10.1016\/j.jacc.2010.01.067"},{"key":"10.1016\/j.carrev.2020.04.011_bb0540","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0545","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0550","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/HPC.0000000000000114","article-title":"The incidence of myocardial injury after loading doses of clopidogrel versus prasugrel in the candidates for percutaneous coronary intervention: a randomized controlled trial","volume":"17","author":"Rahmani","year":"2018","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0555","first-page":"730","article-title":"Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?","volume":"127","author":"Tomaniak","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0560","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jcin.2016.06.046","article-title":"Efficacy and safety of cangrelor in preventing periprocedural complications in patients with stable angina and acute coronary syndromes undergoing percutaneous coronary intervention","volume":"9","author":"Abtan","year":"2016","journal-title":"The CHAMPION PHOENIX Trial JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0565","doi-asserted-by":"crossref","unstructured":"Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87\u2013165.","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"10.1016\/j.carrev.2020.04.011_bb0570","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0575","doi-asserted-by":"crossref","unstructured":"The EPILOG Investigators. Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689\u201396.","DOI":"10.1056\/NEJM199706123362401"},{"key":"10.1016\/j.carrev.2020.04.011_bb0580","doi-asserted-by":"crossref","unstructured":"Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. The Lancet. 1997;349:1422\u20138.","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"10.1016\/j.carrev.2020.04.011_bb0585","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel","volume":"350","author":"Kastrati","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0590","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1161\/01.CIR.0000148956.93631.4D","article-title":"Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel","volume":"110","author":"Mehilli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0595","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacc.2004.03.042","article-title":"The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE trial","volume":"44","author":"Valgimigli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0600","first-page":"762","article-title":"Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents\u2014the PETITION study: a prospective, randomized, multicenter study","volume":"85","author":"Zhang","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0605","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0610","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jacc.2010.10.030","article-title":"Efficacy and safety of glycoprotein IIb\/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines","volume":"57","author":"Winchester","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0615","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0620","first-page":"98","article-title":"Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention","volume":"36","author":"D\u00edez","year":"2009","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0625","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ahj.2007.06.023","article-title":"Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents","volume":"154","author":"Feldman","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0630","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2020.04.011_bb0635","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu283","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0640","first-page":"e44","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention","volume":"58","author":"Levine","year":"2011","journal-title":"A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions"},{"key":"10.1016\/j.carrev.2020.04.011_bb0645","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000158485.70761.67","article-title":"Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: arixtra study in percutaneous coronary intervention: a randomized evaluation (ASPIRE) pilot trial","volume":"111","author":"Mehta","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0650","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0655","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2020.04.011_bb0660","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cvr\/cvn114","article-title":"Remote ischaemic preconditioning: underlying mechanisms and clinical application","volume":"79","author":"Hausenloy","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carrev.2020.04.011_bb0665","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.repc.2013.02.012","article-title":"Myocardial remote ischemic preconditioning: from pathophysiology to clinical application","volume":"32","author":"Costa","year":"2013","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0670","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.108.809723","article-title":"Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial","volume":"119","author":"Hoole","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0675","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.amjcard.2014.03.043","article-title":"Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention","volume":"113","author":"Zografos","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0680","doi-asserted-by":"crossref","unstructured":"Pei H, Wu Y, Wei Y, Yang Y, Teng S, Zhang H. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials. PLoS One. 2014;9:e115500-e.","DOI":"10.1371\/journal.pone.0115500"},{"key":"10.1016\/j.carrev.2020.04.011_bb0685","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4244\/EIJV9I12A244","article-title":"Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials","volume":"9","author":"D\u2019Ascenzo","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.011_bb0690","first-page":"930","article-title":"Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial","volume":"81","author":"Prasad","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0695","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2017.02.028","article-title":"Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: a randomized controlled trial","volume":"236","author":"Miyoshi","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0700","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1253\/circj.CJ-17-1000","article-title":"Protective effect of remote ischemic preconditioning on myocardial damage after percutaneous coronary intervention in stable angina patients with complex coronary lesions \u2014 subanalysis of a randomized controlled trial \u2014","volume":"82","author":"Ejiri","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0705","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.carrev.2020.04.011_bb0710","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"10.1016\/j.carrev.2020.04.011_bb0715","doi-asserted-by":"crossref","unstructured":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4S). Lancet. 1994;344:1383\u20139.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"10.1016\/j.carrev.2020.04.011_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115500","article-title":"Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials","volume":"9","author":"Pei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.carrev.2020.04.011_bb0725","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0730","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.carrev.2018.07.016","article-title":"Impact of statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"19","author":"Soud","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.04.011_bb0735","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2020.04.011_bb0740","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0008-6363(00)00146-2","article-title":"Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability","volume":"47","author":"Koh","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carrev.2020.04.011_bb0745","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2459\/JCM.0b013e32833b929c","volume":"11","author":"Patti","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.carrev.2020.04.011_bb0750","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.RES.33.3.353","article-title":"Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs","volume":"33","author":"Reimer","year":"1973","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2020.04.011_bb0755","first-page":"498","article-title":"Myocardial protection with a beta blocker and glycoprotein IIb\/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit","volume":"72","author":"Leesar","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0760","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1161\/01.CIR.0000072787.25131.03","article-title":"Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.011_bb0765","doi-asserted-by":"crossref","unstructured":"Park H, Otani H, Noda T, Sato D, Okazaki T, Ueyama T, et al. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention. Int J Cardiol 2013;167:1547\u201351.","DOI":"10.1016\/j.ijcard.2012.04.096"},{"key":"10.1016\/j.carrev.2020.04.011_bb0770","first-page":"488","article-title":"Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb\/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome","volume":"72","author":"Uretsky","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0775","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/eurheartj\/ehi709","article-title":"Effects of metoprolol therapy on cardiac troponin-I levels after elective percutaneous coronary interventions","volume":"27","author":"Atar","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.011_bb0780","first-page":"299","article-title":"Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial","volume":"14","author":"Michaels","year":"2002","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0785","first-page":"19","article-title":"Differential release of cardiac enzymes after percutaneous coronary intervention","volume":"65","author":"Matthews","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.011_bb0790","first-page":"270","article-title":"Pretreatment with intracoronary diltiazem reduces non-Q-wave myocardial infarction following directional atherectomy","volume":"9","author":"Jalinous","year":"1997","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0795","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2147\/VHRM.S2998","article-title":"The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions","volume":"4","author":"Gulmez","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.carrev.2020.04.011_bb0800","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/clc.20580","article-title":"Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention","volume":"32","author":"Arora","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.carrev.2020.04.011_bb0805","doi-asserted-by":"crossref","unstructured":"ENCORE Investigators. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I study (evaluation of nifedipine and cerivastatin on recovery of coronary endothelial function). Circulation. 2003;107:422\u20138.","DOI":"10.1161\/01.CIR.0000046488.52939.BF"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920302153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920302153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:18:04Z","timestamp":1761560284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920302153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":161,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1553838920302153"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.04.011","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periprocedural Myocardial Injury: Pathophysiology, Prognosis, and Prevention","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}